UpHealth, Inc (UPH): Price and Financial Metrics
GET POWR RATINGS... FREE!
UPH Stock Price Chart Interactive Chart >
UPH Price/Volume Stats
| Current price | $1.88 | 52-week high | $12.12 |
| Prev. close | $1.85 | 52-week low | $1.61 |
| Day low | $1.78 | Volume | 1,182,500 |
| Day high | $1.89 | Avg. volume | 740,484 |
| 50-day MA | $3.61 | Dividend yield | N/A |
| 200-day MA | $7.68 | Market Cap | 271.19M |
UpHealth, Inc (UPH) Company Bio
UpHealth, Inc. operates as a digital health services company. The company provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. It serves empowering providers, health systems, health plans and governments, employers, and educational institutions. The company is based in Delray Beach, Florida.
Latest UPH News From Around the Web
Below are the latest news stories about UpHealth Inc that investors may wish to consider to help them evaluate UPH as an investment opportunity.
UpHealth Appoints Sarah Arnquist as Senior Vice President of the Behavioral Health BusinessUpHealth, Inc., (NYSE:UPH) has appointed an experienced health care executive, Sarah Arnquist, to its senior leadership team. Arnquist who joined UpHealth effective immediately, will serve as senior vice president of the Behavioral Health Business. |
UpHealth, Inc. Announces Closing Of Over-Allotment Option In Public Offering Of Common StockUpHealth, Inc. (NYSE: UPH) ("UpHealth" or the "Company") today announced that it issued an additional 3,450,000 shares of its common stock, par value $0.0001 per share (the "Common Stock"), pursuant to the underwriters' exercise in full of their over-allotment option in connection with the Company's previously announced public offering (the "Offering"). After giving effect to the full exercise of the over-allotment option, the total number of shares sold by the Company in the Offering was 26,450 |
UpHealth, Inc. Announces NUTRAscriptives™ Direct, Expedited Delivery For Clinical-Grade Nutritional SupplementsUpHealth, Inc. (NYSE: UPH) announced an expansion of its NUTRAscriptives™ product line of clinical-grade supplements distributed online, in retail stores and directly by providers. NUTRAscriptives™ Direct offers providers an easy-to-support business model to offer patients high quality supplements to augment their care plans. The new service further extends UpHealth leadership in the management of health with personalized protocols. |
UpHealth, Inc. Announces Pricing of $40.25 Million Public Offering of Common StockUpHealth, Inc. (NYSE: UPH) ("UpHealth" or the "Company") today announced the pricing of its previously announced underwritten public offering (the "Offering") of 23,000,000 shares of its common stock, par value $0.0001 per share (the "Common Stock"), at a public offering price of $1.75 per share. In addition, the underwriters have been granted a 30-day option to purchase up to 3,450,000 additional shares of Common Stock from the Company at the public offering price, less underwriting discounts a |
UpHealth Expands Globally by Signing Partnership to Bring State-of-the-Art Healthcare to the Democratic Republic of CongoUpHealth, Inc. (NYSE:UPH) today announced, that through a venture with TSHELA, a partner of UpHealth in this project, it has entered into an agreement with the Democratic Republic of Congo (DRC) to build 260 state-of-the-art digital clinics and healthcare centers to provide high-quality, affordable healthcare across the country. |
UPH Price Returns
| 1-mo | -50.66% |
| 3-mo | -69.92% |
| 6-mo | -81.24% |
| 1-year | -81.50% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -82.83% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...